The synaptic function of parkin
Open Access
- 23 February 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in Brain
- Vol. 140 (9) , 2265-2272
Abstract
Loss of function mutations in the gene PARK2, which encodes the protein parkin, cause autosomal recessive juvenile parkinsonism, a neurodegenerative disease characterized by degeneration of the dopaminergic neurons localized in the substantia nigra pars compacta. No therapy is effective in slowing disease progression mostly because the pathogenesis of the disease is yet to be understood. From accruing evidence suggesting that the protein parkin directly regulates synapses it can be hypothesized that PARK2 gene mutations lead to early synaptic damage that results in dopaminergic neuron loss over time. We review evidence that supports the role of parkin in modulating excitatory and dopaminergic synapse functions. We also discuss how these findings underpin the concept that autosomal recessive juvenile parkinsonism can be primarily a synaptopathy. Investigation into the molecular interactions between parkin and synaptic proteins may yield novel targets for pharmacologic interventions.Keywords
Funding Information
- CARIPLO foundation (2012-0593)
- Telethon Foundation (GGP15167)
This publication has 71 references indexed in Scilit:
- Hyperkinetic disorders and loss of synaptic downscalingNature Neuroscience, 2016
- Synaptic failure and α‐synucleinMovement Disorders, 2016
- Pathologic and therapeutic implications for the cell biology of parkinMolecular and Cellular Neuroscience, 2015
- A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s diseaseJournal of Neural Transmission, 2014
- Primary Skin Fibroblasts as a Model of Parkinson's DiseaseMolecular Neurobiology, 2012
- Parkin promotes intracellular A 1-42 clearanceHuman Molecular Genetics, 2009
- Space, time and dopamineTrends in Neurosciences, 2007
- Effect of Riluzole on Dyskinesia and Duration of the ON State in Parkinson Disease PatientsClinical Neuropharmacology, 2004
- SEPT5_v2 is a parkin-binding proteinMolecular Brain Research, 2003
- Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson diseaseNature Medicine, 2001